Home
Vaxart

Vaxart Market Share Analysis for January 2026

Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection.

Health > Biotechnology and Pharmaceuticals

Domainvaxart.com

Year Founded2004

Employees51 - 200

Annual Revenue$2M - $5M

Vaxart

Vaxart (including company regionals)

vaxart.com

See more website traffic and engagement information

Vaxart Revenue up to January 2026 is 2M - 5M

revenue generated by Vaxart top domains

Vaxart top domains revenue over 3 years

Revenue for Vaxart top domains

vaxart.com2M - 5M

See more with Sales Intelligence

Total visits to Vaxart's top domains

Understand Vaxart market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vaxart.com4.8K

See more with Sales Intelligence

Avg. visit duration in Vaxart's top domains

Analyze Vaxart engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

vaxart.com00:00:48

See more with Sales Intelligence

Avg. pageviews on Vaxart's top domains

See how Vaxart keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vaxart.com2.94

See more with Sales Intelligence

Vaxart top competitors by domain

Top similar sites in January 2026, ranked by their affinity

sanofipasteur.comCompany NameSanofi Pasteur SAEmployees> 10001HQFrance, LyonAnnual revenue> $1BTotal visits286Health > Biotechnology and Pharmaceuticals

Top technologies used by Vaxart

These are the website technologies, by industry, used by Vaxart top domains

Advertising (10)

DoubleClick

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

Widget (3)

Twemoji

More Technologies

10

See all

News & Signals from Vaxart

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVaxart Inc. attended event Global BioInnovation Forum on Jan 8th '26.SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) - Vaxart, Inc. (OTCQX: VXRT) ("Vaxart or "the Company"), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies.

NewsVaxart Inc. attended event IDWeek 2025 on Oct 19th '25.Vaxart (OTCQX: VXRT) will present research on its second-generation norovirus oral pill vaccine candidate at IDWeek 2025 in Atlanta, held October 19 - 22, 2025.

NewsVaxart Inc. is developing therapeutic vaccine for HPV.Vaxart is developing oral vaccines for coronavirus, norovirus, influenza, and a therapeutic vaccine for HPV.